| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |